Brief: Sk Biopharmaceuticals Co To Invest $20 Million In Lifesci Venture Partners Iii, Lp
May 11 (Reuters) - SK Biopharmaceuticals Co Ltd
326030.KS :
* SK BIOPHARMACEUTICALS CO: TO INVEST $20 MILLION IN
LIFESCI
VENTURE PARTNERS III, LP
Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals Co
See all newsInsilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
Signs Joint Rd Partnership Agreement With Insilico Medicine
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
Brief: SK Life Science Announces FDA Acceptance For Review Of New Drug Application For Cenobamate Oral Suspension
Announces Pharmaceutical Supply Contract